COVID-19 R&D Support Needs
Thank you for your interest in the R&D Loan Scheme, please note that current applications are nearing the scheme's limit.
While we are not currently taking registrations for the R&D Loan Scheme waitlist, we are interested in tracking business R&D needs arising from COVID-19 impacts. We welcome you to provide us with a picture of how your R&D has been impacted by COVID-19, along with your resulting needs, via this form.
This information will inform our ongoing planning and discussions for additional support in this space.
In the meantime we encourage you to take look at other forms of R&D funding available such as Getting Started Grants, R&D Project Grants, the R&D Tax Incentive, and grants to bring on post Graduate students for R&D projects. You can find out more via our R&D Funding webpage:
Your Company's Name:
Your Company's NZBN:
Your NZBN can be found via:
. Please note that this is a 13 digit number and is different to your companies office number.
Your Phone Number:
Is your company undertaking research and development activities (R&D) in New Zealand?
Our R&D Definition: RESEARCH is original and planned investigation undertaken with the prospect of gaining new scientific or technical knowledge and understanding. DEVELOPMENT is the application of research findings or other knowledge to a plan or design for the production of new or substantially improved materials, devices, products, processes, systems or services before the start of commercial production or use. NOTE: Further clarification and direction as to R&D Definition and Eligible Spend will be provided when applications open.
How much do you expect to spend on R&D over the next year (July '20 to June '21)?
$0 - $50,000
$50,000 - $100,000
$100,000 - $150,000
$150,000 - $200,000
$200,000 - $250,000
$250,000 - $300,000
$300,000 - $350,000
$350,000 - $400,000
$400,000 - $450,000
$450,000 - $500,000
Has your company's R&D program been negatively impacted by COVID-19 (or is it expected to be impacted in the next 12 months)?
To what extent do you anticipate your ability to fund your R&D program has been impacted by COVID-19 (on a percentage basis)?
Where '0' is not impact, '5' would be half of our funds intended to support R&D are no longer available and '10' would be all funds intended to support R&D would no longer be available.
No Impact on our ability to fund R&D
All funds we intended to spend on R&D are no longer available due to COVID-19
How has/will COVID-19 impact your R&D program?
Select all that apply.
Closure of national markets
Closure of international markets
Closure of national supply chains
Closure of international supply chains
Increased costs due to H&S compliance with each alert level
No access to staff or expert support to do the work
Having to let staff go or reduce their pay
Having to re-negotiate contracts to reduce expenses and costs
No access to international experts
Investor funding has been affected and uncertain
Not digitally enabled to operate
Delay in our ability to launch our product/service to market
A drop in available capital due to reduced revenues from sales
A drop in available capital due to reduced revenues from capital raising
A positive impact due to new opportunities
An increase in available capital due to increased revenue from sales
An increase in available capital due to increased revenue from capital raising
None - We have not had any negative impact on our business
Send me a copy of my responses.
Never submit passwords through Google Forms.
This form was created inside of Callaghan Innovation.